Sat.Jun 04, 2022 - Fri.Jun 10, 2022

article thumbnail

How celebrity investor Mark Cuban is tackling out-of-control drug prices

pharmaphorum

American entrepreneur and investor Mark Cuban tells us why he and his partners launched the Mark Cuban Cost Plus Drug Company (MCCPDC), a public-benefit corporation and online pharmacy that provides patients access to medications at a lower cost. . US drug prices have soared over the last several decades, causing, at times, financial hardship for patients and their families, so Cuban says he developed MCCPDC with a simple mission – “to be the low-cost provider of medications to patients.”.

Labelling 144
article thumbnail

How to Make a Pharmacy Poster Presentation

Find Your Script

Today we are talking about how to prepare a poster for pharmacy conferences plus templates to use! Stay until the end where I share the best step to take. . Watch & Subscribe on our YouTube Channel ! [link]. Hi, I’m Dr. Jessica Louie and I’m an Associate Professor, Board-Certified Critical Care Pharmacist and entrepreneur. I help people find meaning beyond a job title and let go of burnout.

130
130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Can the industry elevate the success rate of cancer trials?

Outsourcing Pharma

During the upcoming BIO International Convention, experts from CerFlux, the MD Anderson Cancer Center, and Aga Khan University will weigh in with insights.

111
111
article thumbnail

Controlling Diabetes: Advances & Adherence

Pharmaceutical Commerce

Proper control of type 1 and 2 diabetes can greatly reduce the personal impact and economic burden of this pervasive public health condition. To that end, stakeholders are exploring many parallel routes to help individuals and society maintain the upper hand, as the toll of diabetes continues to skyrocket.

105
105
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Four things you need to know about FDA regulations and digital health

pharmaphorum

If you work in pharma, the chances are you’re no stranger to the United States Food and Drug Administration, or FDA, which regulates pharmaceuticals. But if you’re becoming more involved with the world of digital health, as many pharma companies are these days, you may find that your old FDA knowledge isn’t much help in knowing what will be required of you.

FDA 133
article thumbnail

Cambridge Pharma promises to boost drug development

Pharma Times

New facility opens on the Cambridge Research Park offering pharmaceutical development services

52

More Trending

article thumbnail

The Impact of War on Drug Supply Chain

Pharmaceutical Commerce

A conversation with EY life sciences leaders Jim Welch and Jay Welsh.

87
article thumbnail

How digital is transforming the commercial leader’s role in biopharma

pharmaphorum

Pharma’s evolving role in patient care. The digital revolution has already reshaped the commercial engine of biopharma companies. Pharma’s digital initiatives now routinely enable new channels that educate and market to patients, physician engagement that is more efficient and effective, and novel payment mechanisms and distribution models that improve access to therapies.

article thumbnail

Veeva MyInsights: Where is the value of data?

Viseven

There are tasks we, humans, can perform well with our eyes closed. Managing a successful multichannel customer engagement strategy is not on that list. Not seeing your output is about the second worst thing if you are a marketer, brand or product manager (after producing no output). In life sciences, that field of extra responsible decision making, detailed insights after each step are, of course, an especially prized possession.

article thumbnail

Sanofi hemophilia A drug lands breakthrough therapy designation

Outsourcing Pharma

Efanesoctocog alfa is an investigational factor III therapy designed to prevent bleeds and bleeding episodes in patients diagnosed with the rare disorder.

76
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Dealing with Dangerous Goods

Pharmaceutical Commerce

The packaging and shipping of dangerous goods (DG) adds further challenges. to the distribution pressures brought about by the pandemic.

article thumbnail

Apple adds medication tracking to iPhone and Apple Watch

pharmaphorum

Owners of an iPhone or Apple Watch have a new health feature, an app called Medications, that will help them manage and track their use of medicines. The new tool works as a component of Apple’s Health app and will let users add drugs or other health products like vitamins and supplements to a personal list – either by scanning a label or finding the product in a directory – and create custom schedules for them.

article thumbnail

Inca Trail Fundraising Adventure (Pete Ward)

NF2 BioSolutions

Pete hiked the Inca Trail to raise funds for NF2 BioSolutions UK! He has already raised £7600 as of the start of June and Pete’s fundraising page is open for donations until the 30th June 2022. Here is how his adventure panned out… Day 1 of my Inca Trail adventure was a nice breaking in day, with a steady but challenging trek. We started off at 8am (after waking at 3am for a 2.5 hour coach journey to start point) and finished off at 5.00pm with a beer and a view.

52
article thumbnail

BIO International 2022 to bring insights, athletes to San Diego

Outsourcing Pharma

Coming back to the real world June 13-16, the industry event will offer face-to-face learning, networking opportunities, and fun, star-studded opportunities.

59
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

From Point-in-time to Real-time

Pharmaceutical Commerce

Why ‘real-time-all-the-time’ supply chain operations are fundamental to biopharma success.

52
article thumbnail

Eversana aims athletes’ mental coaching at pharma sales reps

pharmaphorum

Eversana’s suite of commercialisation tools for pharma companies will soon have a new component – cognitive behavioural training tools designed to improve the performance of sales representatives. The addition to the company’s portfolio – which already spans services like patient support, digital engagement, dispensing and distribution, and data/analytics – has arrived on the back of an alliance with business and wellness coaching specialist Limitless Minds.

118
118
article thumbnail

CPHI China opens for international partnering after China rises in CPHI Index

Pharma Mirror

Shanghai/Amsterdam: CPHI & P-MEC China opens its online international partnering platform as pharmaceutical and biopharmaceutical industries in the country report strong underlying conditions and see increases in all categories of the most recent CPHI Pharma Index [1] – an annual score of each country’s pharma industry strength – with its overall score rising by 7.2%, the largest increase of any nation.

52
article thumbnail

DIA ‘fun run’ to honor clinical trial patient participants

Outsourcing Pharma

The June 20 Medical Heroes Appreciation 5k Run and Walk, scheduled during the DIA Global Annual Meeting in Chicago, salutes contributions of trial volunteers.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

The Promise of Industry 4.0

Pharmaceutical Commerce

Pharma supply chain management will be one of the earliest beneficiaries of the Fourth Industrial Revolution, and the potential of ‘networks of networks’.

52
article thumbnail

Praxis wields the axe as lead depression drug fails

pharmaphorum

Shares in Praxis Precision Medicines were in freefall today after the company’s efforts to develop a new therapy for major depressive disorder (MDD) ended in failure, forcing a restructuring and staff cuts. The selloff followed the announcement of the phase 2/3 Aria study results with PRAX-114 as a monotherapy for MDD, which showed the GABA positive allosteric modulator was unable to show a significant benefit on any of the study’s primary and secondary endpoints.

111
111
article thumbnail

Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China

Pharma Mirror

SYDNEY, Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, is sponsoring the Endpoints ASCO 22 “Accelerating clinical development in China and the US” Register here [link] JUNE 711:00am – 11:45am ET (1:00 – 1:45 local time)Novotech Booth at ASCO #14115 The virtual session will cover the latest on the clinical trial landscape and infrastructure in China and includes Novotech’s DCT partner, Obvio Health, on DC

52
article thumbnail

DIA offers tracks to deliver focused educational experience

Outsourcing Pharma

Offering 13 topic tracks to choose from, the DIA Global Annual Meeting (scheduled June 19-23) lets attendees chose the path that fits their unique interests.

52
article thumbnail

Food for Thought from France

Pharmaceutical Commerce

A reflection on the industry's effort to foster and facilitate sustainability.

52
article thumbnail

Sanofi furthers its digital ambitions with Paris accelerator

pharmaphorum

Sanofi has launched a new initiative in its drive to integrate digital technologies throughout its business, setting up an accelerator based in Paris that will serve as the lynchpin of the effort. The accelerator has been set up to “develop products and solutions that will support Sanofi’s mission to transform the practice of medicine with the use of digital, data and artificial intelligence (AI)”, said the drugmaker.

105
105
article thumbnail

June is National Safety Month

OctariusRx

June is National Safety Month and at OctariusRx we recognize and support the National Safety Council’s efforts to build and advocate for a culture of safety. When it comes to safety, too much is never enough. Our team of consultant pharmacists works tirelessly to ensure our clients and patients are always as safe as possible. From our relentless focus on safe medication management, to guidance on workplace safety, we strive daily to develop and support a culture that leads to safety, regulatory

article thumbnail

New ClinOne executive pursuing lifelong interest in human health

Outsourcing Pharma

Former Medable vice president Brian Ongioni has joined the trial tech provider as vice president of product, continuing a quest for patient-focused solutions.

52
article thumbnail

Pharmaceutical Commerce - June 2022 Issue (PDF)

Pharmaceutical Commerce

Click the title above for a link to open the Pharmaceutical Commerce June 2022 issue in an interactive PDF format.

52
article thumbnail

Is COVID in pregnancy linked to infant development issues?

pharmaphorum

Babies born to mothers who contracted COVID-19 during seem to be at slightly higher risk of neurodevelopmental delays, say US researchers, although they caution their findings are preliminary. Their retrospective study looked at more than 7,500 infants delivered during the pandemic, including 222 born to mothers with a positive COVID-19 test during pregnancy.

article thumbnail

Bachem and Eli Lilly link up to advance oligonucleotide products

Pharma Times

The agreement will see the two companies expand current oligonucleotide technologies

50
article thumbnail

Growing the labor pool

Pharma Manufacturing

Fulfilling the promise of CGT will require a carefully cultured talent ecosystem

45
article thumbnail

Steroid Use in ARDS With and Without COVID-19

Pharmacy Friday Pearls

Download PDF. Introduction. Steroid use in ARDS has been a highly debated topic around dosing, which steroid, durations, when to initiate therapy. With the emergence of COVID-19, the debate has resurfaced along with numerous trials. The thought behind using steroids in this patient population is to use the anti-inflammatory and anti-proliferative effects of glucocorticoids to mitigate the progression and limit the severity of this inflammatory disease.

article thumbnail

EU first to clear Roche’s lymphoma bispecific mosunetuzumab

pharmaphorum

Roche has secured its first regulatory approval for mosunetuzumab, a first-in-class CD20xCD3 bispecific antibody, as a treatment for patients with follicular lymphoma (FL) in the EU. The European Commission has approved mosunetuzumab under the Lunsumio trade name for relapsed or refractory FL, the most common slow-growing form of non-Hodgkin lymphoma (NHL), after two or more prior systemic therapies.

article thumbnail

Takeda’s dengue vaccine candidate delivers continued protection

Pharma Times

Vital dengue vaccine offers over four years’ protection following successful clinical trial